Revenue (Tables)

9 Months Ended

Sep. 26, 2025

Revenue from Contract with Customer [Abstract]

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 26, 2025 and September 27, 2024 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.


	Biotechnology		Life Sciences		Diagnostics		Total
For the Three-Month Period Ended September 26, 2025:
Geographical region:
North America(a)	$	624	$	728	$	1,228	$	2,580
Western Europe	587		392		417		1,396
Other developed markets(b)	89		130		97		316
High-growth markets(c)	498		542		721		1,761
Total	$	1,798	$	1,792	$	2,463	$	6,053

Revenue type:
Recurring	$	1,590	$	1,216	$	2,211	$	5,017
Nonrecurring	208		576		252		1,036
Total	$	1,798	$	1,792	$	2,463	$	6,053

For the Three-Month Period Ended September 27, 2024:
Geographical region:
North America(a)	$	503	$	796	$	1,157	$	2,456
Western Europe	587		365		368		1,320
Other developed markets(b)	78		120		101		299
High-growth markets(c)	485		501		737		1,723
Total	$	1,653	$	1,782	$	2,363	$	5,798

Revenue type:
Recurring	$	1,422	$	1,228	$	2,127	$	4,777
Nonrecurring	231		554		236		1,021
Total	$	1,653	$	1,782	$	2,363	$	5,798



	Biotechnology		Life Sciences		Diagnostics		Total
For the Nine-Month Period Ended September 26, 2025:
Geographical region:
North America(a)	$	1,779	$	2,211	$	3,610	$	7,600
Western Europe	1,861		1,164		1,222		4,247
Other developed markets(b)	235		371		282		888
High-growth markets(c)	1,385		1,503		2,107		4,995
Total	$	5,260	$	5,249	$	7,221	$	17,730

Revenue type:
Recurring	$	4,741	$	3,566	$	6,496	$	14,803
Nonrecurring	519		1,683		725		2,927
Total	$	5,260	$	5,249	$	7,221	$	17,730

For the Nine-Month Period Ended September 27, 2024:
Geographical region:
North America(a)	$	1,624	$	2,362	$	3,536	$	7,522
Western Europe	1,700		1,111		1,154		3,965
Other developed markets(b)	238		361		295		894
High-growth markets(c)	1,328		1,463		2,165		4,956
Total	$	4,890	$	5,297	$	7,150	$	17,337

Revenue type:
Recurring	$	4,209	$	3,628	$	6,424	$	14,261
Nonrecurring	681		1,669		726		3,076
Total	$	4,890	$	5,297	$	7,150	$	17,337

(a) The Company defines North America as the United States and Canada.

(b) The Company defines other developed markets as all the markets of the world that are not North America, Western Europe or high-growth markets.

(c) The Company defines high-growth markets as developing markets of the world experiencing accelerated growth, over extended periods, in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.